Euro-BioImaging update regarding COVID-19


Published April 7, 2020
Scientific application

Following closely the Covid-19 situation, Euro-BioImaging asks everyone involved, including Euro-BioImaging users, to align with the recommendations of their relevant national health departments.

Euro-BioImaging will process the online submission of new user proposals as before, but flexibility needs to be applied when it comes to scheduling a physical user visit until available information on the European situation allows again for reliable and safe travel planning. Euro-BioImaging is also looking into the implementation of additional activities and services that do not require physical traveling and ways to keep a constructive momentum during these exceptional times.

Regarding any upcoming meetings, Euro-BioImaging will continue following the general development and act in accordance.


More news from Euro-BioImaging

CanSERV user story

August 27, 2025

Multiplex imaging of lymph nodes: How Euro-BioImaging is advancing cancer research through the canSERV funding

The immune system plays an important role in fighting cancer but can also be a pathway of metastasis – therefore understand the interactions of…

August 26, 2025

Euro-BioImaging at IUIS 2025: Building Bridges with the Immunology Community

Vienna, August 17–22, 2025 – More than 5,000 researchers from over 150 countries gathered in Vienna for the 19th International Congress of Immunology…

Euro-BioImaging booth at Turku PET Symposium 2025

August 11, 2025

Euro-BioImaging at Turku PET Symposium 2025

In June 2025, Euro-BioImaging team members were delighted to attend the Turku PET Symposium, organised by the Turku PET Centre, part of our Finnish…